Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00492011 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult Volunteers
A Phase 4 study of Circadian Dysregulation, sponsored by Takeda.
- Completed
- Registry status
- Phase 4
- Development phase
- 110
- Enrollment target
- 4
- Study locations
NCT00492011 is a Phase 4 study of Circadian Dysregulation that has completed, run by Takeda. The registered enrollment target is 110 participants, above the 60-participant average among 10 other Circadian Dysregulation trials with a reported enrollment target (83% higher). The trial reports 4 study locations across 3 states.
The verdict
NCT00492011, a Phase 4 study of Circadian Dysregulation, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 110 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study to determine the degree to which ramelteon, once daily (QD), can reduce the insomnia symptoms associated with rapid, eastward travel across 5 time zones.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Ramelteon
Study Locations (4)
Florida
- - Miami
- - Pembroke Pines
Hawaii
- - Honolulu
New York
- - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2007-02 |
| Est. Completion | 2007-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00492011
The ClinicalTrials.gov registry entry for NCT00492011 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 60-participant average among 10 other Circadian Dysregulation trials with a reported enrollment target (83% higher). The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Circadian Dysregulation appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00492011 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Florida, Hawaii, New York.
Frequently Asked Questions
What is clinical trial NCT00492011 about?
NCT00492011 is a clinical study titled "Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult Volunteers". The purpose of this study to determine the degree to which ramelteon, once daily (QD), can reduce the insomnia symptoms associated with rapid, eastward travel across 5 time zones.
What is the current status of trial NCT00492011?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 110 participants. The study started on 2007-02. Estimated completion is 2007-08.
What conditions does trial NCT00492011 study?
This clinical trial studies the following conditions: Circadian Dysregulation.
What interventions are being tested in trial NCT00492011?
The interventions under investigation include: Placebo (DRUG), Ramelteon (DRUG).
Who is sponsoring clinical trial NCT00492011?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00492011 being conducted?
This trial has 4 study locations across Florida, Hawaii, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Circadian Dysregulation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment
RECRUITING · NA
-
Feasibility of Light Therapy in the Pediatric Intensive Care Unit (ICU)
RECRUITING · NA
-
Nighttime Synchrony of Your Nutrition and Circadian Health
RECRUITING · NA
-
Body Weight, Sleep, and Heart Health
ACTIVE NOT RECRUITING
-
Circadian Health Regulation and Optimization for Rejuvenation Outcomes
ACTIVE NOT RECRUITING · NA
-
Maintaining Behavior Change: An Evaluation of a Habit-based Sleep Health Intervention
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.